In the relapse-free survival (RFS) analyses based on sequencing data of 1,925 NSCLC patients, high NOTCH3 and NCBP2 expression levels were associated with shorter NSCLC survival times (Figure 6C, P < 0.01). This evidence concerns the gene NCBP2 and non-small cell lung carcinoma.